Search PubMed⌕ Search

Biomedical subjects

D Kerr

Publications and source records attributed to D Kerr.

At least 217 records · Page 12Linked to original sources

Constrictive pericarditis with dwarfism in two siblings (mulibrey nanism).

Two siblings with marked dwarfism, now 11 and 19 years of age, have been followed from infancy. The girl had frequent episodes of pneumonitis and presented at age 4 years with hepatic enlargement and ascites which proved to be due to constrictive pericarditis. The boy presented with growth failure and pseudohydrocephalus. He had fibrous dysplasia of the tibia and a pathologic fracture; acute hepatic congestion followed physical activity at age 13 years and led to the diagnosis of constrictive pericarditis. Muscle function was normal, there was no evidence for a primary liver disorder, and mental development was normal so that the coined word "mulibray" seemed inappropriate. Pericardiectomy produced only partial improvement; both patients have hepatic enlargement and continue to need diuretics. A third patient with dwarfism, frequent respiratory infections, and pericardial calcification has certain features of the syndrome.

Adolescent↗

The curriculum.

Explore the source record for details and available documents.

Curriculum↗

Treating obese patients with poorly controlled diabetes: confessions of an insulin therapist.

How to treat the obese, poorly controlled patient with diabetes is a common and vexed question. Using insulin without giving thought to ameliorating the inevitable weight gain will cause desperation in the physician and despondency in the patient. Novel attempts at dietary manipulation before commencing insulin can be beneficial provided there is close scrutiny of short-term changes in weight and metabolic parameters. Combinations of insulin and metformin can also be helpful at an early stage. It may be helpful to use insulin as a therapeutic trial provided the goals of therapy are agreed with the patient at the outset. Above all it is important to avoid therapeutic nihilism - a minority of fat people may be jolly but few are truly happy.

Diabetes Mellitus↗

Snapshot of acute asthma: treatment and outcome of patients with acute asthma treated in Australian emergency departments.

AIMS: To characterize presentations due to acute asthma at Australian emergency departments (ED), including their severity, treatment and disposition. METHODS: This prospective, observational study involved 38 departments of emergency medicine throughout -Australia participating in the Snapshot of Asthma Study Group project 2000 and 2001. Data were collected for patients presenting with acute asthma between 21 August 2000 and 3 September 2000, and 20 August 2001 and 2 September 2001 and included demographics, severity classification, treatment and disposition. RESULTS: There were 1340 acute asthma presentations in the study periods. Of these presentations, 67% were for children aged <15 years. Asthma severity (according to the Australian National Asthma Guidelines classification) was 'mild' in 49% of cases; 'moderate' in 45% of cases; and 'severe' in 6% of cases. Treatment administered included: (i) salbutamol to 90%, (ii) ipratropium bromide to 59% and (iii) corticosteroids to 71%. Only six patients received aminophylline. Spacer use for salbutamol was rare (1%) in adults and only moderate (43%) in children. Sixty-five percent of patients were discharged home from the ED. Less than 1% of patients required ventilatory assistance, of which half was provided non-invasively. One percent of patients were admitted to the intensive-care unit or high-dependency unit. CONCLUSION: Overall adherence to treatment guidelines was good. There appears to be underuse of spacers and corticosteroids in some groups and overuse of ipratropium bromide. The majority of patients are treated and discharged from the ED.

Adolescent↗

Fluid dynamics in man of an intraperitoneal drug delivery solution: 4% icodextrin.

Interest in targeting drugs into the peritoneal cavity for intra-abdominal cancers or infections is undergoing a revival as recent clinical trials have demonstrated, not only a regional advantage in concentration of the active agent, but also improved long-term outcomes. Solutions currently used for intraperitoneal (IP) drug delivery have short residence times, however, which can limit the exposure of all areas of the peritoneum to the active agent. Icodextrin 4% solution was compared with saline and a glucose-based peritoneal dialysis solution in a clinical study of IP residence time. The study was carried out during the fortnightly rest phase in 9 patients undergoing 5-fluorouracil (5-Fu) IP treatment for colorectal cancer. The volume remaining in the peritoneal cavity was measured at 0, 12, 24, 48, 72, and 96 hr after an instillation of 2 liters of each fluid. Saline (n = 3 dwells) and glucose (n = 3 dwells) peritoneal dialysis solutions were almost fully absorbed by 24 hr, and the patients experienced discomfort when using these solutions. In contrast, icodextrin 4% solution (n = 188 dwells) maintained its instilled volume for up to 48 hr, and half the instilled volume remained after 72 and 96 hr. This result would allow extensive and prolonged coverage of the peritoneal surface. Icodextrin 4% solution may be an effective vehicle to deliver therapeutic agents into the peritoneal cavity.

Aged↗

Patients with type 1 diabetes adapt acutely to sustained mild hypoglycaemia.

The relationship between awareness of, and the catecholamine response to, sustained mild hypoglycaemia was examined in six well-controlled Type 1 diabetic patients (age 24-41 years, HbA1 less than 10.0%) using a hyperinsulinaemic clamp. Blood glucose was maintained at 2.8 mmol l-1 for 90 min with a euglycaemic (4.5 mmol l-1) clamp as a control. After 40 min at a blood glucose of 2.8 mmol l-1, symptom score had increased from 0.2 +/- 0.2 (+/- SE) to 3.0 +/- 0.8 (p less than 0.01), cognitive function (measured by reaction time) deteriorated by 55 +/- 20 ms, and four patients 'felt hypoglycaemic'. This was associated with a rise in plasma adrenaline from 0.48 to 1.30 nmol l-1 (p less than 0.01). However when hypoglycaemia was prolonged to 90 min, symptom score decreased to 1.8 +/- 0.2, none 'felt hypoglycaemic', and reaction time improved by 30 +/- 12 ms, despite a progressive rise in plasma adrenaline to 1.62 nmol l-1. Thus, despite high levels of adrenaline, diabetic patients develop reduced symptoms and no longer 'feel hypoglycaemic' during sustained mild hypoglycaemia.

Acclimatization↗

Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG. European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative Group.

During the last few years several factors have contributed to an increasing change in the medical treatment of advanced colorectal cancer. Among them are the more general acceptance of the impact of chemotherapy on quality of life and survival in first as well as in second-line treatment, the introduction of new drugs and the definition of novel endpoints which can roughly be defined as "patient benefit". For this reason the European Organization for Research and Treatment of Cancer (EORTC) Gastrointestinal Tract Cancer Cooperative Group (GITCCG) felt it was appropriate to organize a workshop with experts from different countries and national groups to discuss in depth several aspects concerning the treatment of patients with advanced colorectal cancer.

Clinical Trials as Topic↗